Entacapone for Parkinson‘s Disease

Entacapone is a selective and reversible inhibitor of the enzyme catechol-O-methyltransferase (COMT).It is used in combination with levodopa and carbidopa (Sinemet) to treat the end-of-dose ‘wearing-off‘ symptoms of Parkinson‘s disease. Entacapone helps the levodopa and carbidopa work better by allowing more of it to reach the brain, where it has its effects.

We manufacture and furnish high quality Entacapone impurities for global markets. More information is available on the official website: https://www.ex-biotech.com. If you have any questions, please send an email to sale@ex-biotech.com. We are looking forward to cooperating with you.